Settlement plan approved for lorazepam, clorazepate overcharges.
D014151:Anti-Anxiety Agents / Q000191:economics*; D003009:Clorazepate Dipotassium / Q000191:economics*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D008140:Lorazepam / Q000191:economics*; D014481:United States; D014485:United States Federal Trade Commission
D014151:Anti-Anxiety Agents; D003009:Clorazepate Dipotassium; D008140:Lorazepam